Angiodynamics (ANGO) Acquisitions (2012 - 2024)

Angiodynamics (ANGO) reported Acquisitions of $3.2 million for Q1 2024, up 501.85% quarter-over-quarter from $540000.0 in Q4 2022.

Angiodynamics (ANGO) Acquisitions (2012 - 2024) Analysis & Trends

Angiodynamics has reported Acquisitions for 11 years, with the latest figure at $3.2 million in Q1 2024.

For the quarter ending Q1 2024, Acquisitions changed N/A year-over-year to $3.2 million; the trailing twelve-month figure through Feb 2024 stood at $3.8 million (up 601.85% YoY), and the FY2012 full-year result was $237.9 million, up 21803.04% from the prior year.
Acquisitions for Q1 2024 stood at $3.2 million, up from $540000.0 in the prior quarter.
The five-year high for Acquisitions was $10.0 million in Q1 2020, with the low at $540000.0 in Q4 2022.
Historically, Acquisitions has averaged $4.3 million across 4 years, with a median of $3.4 million in 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Intuitive Surgical	148.09 Bn	143.69 Bn	1.83 Bn	528.20 Mn
2	Becton Dickinson	41.00 Bn	39.99 Bn	2.15 Bn	-
3	Medline	30.38 Bn	36.22 Bn	1.84 Bn	-
4	Resmed	28.22 Bn	26.56 Bn	890.98 Mn	24.88 Mn
5	West Pharmaceutical Services	23.72 Bn	23.19 Bn	296.40 Mn	-
6	Solventum	13.33 Bn	13.33 Bn	1.10 Bn	-
7	Cooper Companies	13.12 Bn	12.99 Bn	735.40 Mn	-
8	Align Technology	12.86 Bn	11.80 Bn	736.59 Mn	18.96 Mn
9	Baxter International	10.51 Bn	8.47 Bn	891.00 Mn	-
10	Angiodynamics	505.81 Mn	468.00 Mn	41.48 Mn	-

Download Data